Literature DB >> 16816224

Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.

Charles L Bowden1, Joseph R Calabrese, Terence A Ketter, Gary S Sachs, Robin L White, Thomas R Thompson.   

Abstract

OBJECTIVE: This study assessed weight changes in a large cohort of patients with bipolar disorder who were treated with randomly assigned maintenance monotherapies.
METHOD: A post hoc analysis was conducted to assess the effects of lamotrigine, lithium, and placebo administration on body weight in obese and nonobese patients with bipolar disorder from two double-blind, placebo-controlled, 18-month studies.
RESULTS: Mean changes in weight among obese patients (N=155) at week 52 were -4.2, +6.1, and -0.6 kg with lamotrigine, lithium, and placebo, respectively (lamotrigine versus lithium and lithium versus placebo). Among nonobese patients (N=399), mean changes in weight (kg) at week 52 were -0.5, +1.1, and +0.7 with lamotrigine, lithium, and placebo, respectively, with no significant differences among groups.
CONCLUSIONS: Obese patients with bipolar I disorder lost weight while taking lamotrigine and gained weight while taking lithium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816224     DOI: 10.1176/ajp.2006.163.7.1199

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   19.242


  15 in total

1.  Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder.

Authors:  Jennifer E Wildes; Marsha D Marcus; Andrea Fagiolini
Journal:  Psychiatry Res       Date:  2008-09-07       Impact factor: 3.222

2.  Multi-level regulation of PKCδI alternative splicing by lithium chloride.

Authors:  Deena Bader; Rekha S Patel; Ashley Lui; Chetna Thawani; Rea Rupani; Gitanjali Vidyarthi; Niketa A Patel
Journal:  Mol Cell Biol       Date:  2020-12-07       Impact factor: 4.272

3.  A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder.

Authors:  Roger S McIntyre; Susan L McElroy; James M Eudicone; Robert A Forbes; Berit X Carlson; Ross A Baker
Journal:  Prim Care Companion CNS Disord       Date:  2011

4.  Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers.

Authors:  Jess G Fiedorowicz; Del D Miller; Jeffrey R Bishop; Chadi A Calarge; Vicki L Ellingrod; William G Haynes
Journal:  Curr Psychiatry Rev       Date:  2012-02-01

Review 5.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

Review 6.  Obesity in bipolar disorder: an overview.

Authors:  Susan L McElroy; Paul E Keck
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

Review 7.  Face and predictive validity of the ClockΔ19 mouse as an animal model for bipolar disorder: a systematic review.

Authors:  M Kristensen; A A Nierenberg; S D Østergaard
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

8.  Research advances in geriatric depression.

Authors:  George S Alexopoulos; Robert E Kelly
Journal:  World Psychiatry       Date:  2009-10       Impact factor: 49.548

9.  Can body mass index help predict outcome in patients with bipolar disorder?

Authors:  Cynthia Calkin; Caroline van de Velde; Martina Růzicková; Claire Slaney; Julie Garnham; Tomas Hajek; Claire O'Donovan; Martin Alda
Journal:  Bipolar Disord       Date:  2009-09       Impact factor: 6.744

10.  A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder.

Authors:  Anja Tränkner; Christian Sander; Peter Schönknecht
Journal:  Neuropsychiatr Dis Treat       Date:  2013-01-18       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.